AstraZeneca's Three-in-One COPD Inhaler Succeeds in Phase III Trial Post author:Sam Post published:January 25, 2018 Post category:BioPharma Astra has Glaxo and its COPD treatment Trelegy Ellipta squarely in its sights. Source: BioSpace You Might Also Like Genentech Shows Off Positive Results From Phase III HEMLIBRA, TECENTRIQ Studies November 19, 2017 Pharma Giant Bristol-Myers Squibb Plans Layoffs, Effective Oct. 6 August 9, 2017 BioTelemetry Reaches Key Milestone In Tender Offer For LifeWatch Corp June 8, 2017
